Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2024 Earnings Conference Call August 9, 2024 8:00 AM ET
Company Participants
Robert Shawah - CFO
David Luci - President & CEO
Robert DeLuccia - Executive Chairman
Conference Call Participants
Jason McCarthy - Maxim Group
Thomas Yip - H.C. Wainwright
James Molloy - Alliance Global Partners
Operator
Greetings. Welcome to the Acurx Pharmaceuticals Second Quarter 2024 Financial Results. At this time, all participants are in listen-only mode. Question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded.
At this time, I'll now turn the conference over to Rob Shawah, Chief Financial Officer. Rob, you may begin.
Robert Shawah
Thank you, Rob. Good morning, and welcome to our call. This morning, we issued a press release providing financial results and company highlights for the second quarter 2024, which is available on our website at acurxpharma.com. Joining me today is Dave Luci, President and CEO, who will give a corporate update and outlook. After that, I'll provide some highlights of the financials from the quarter ended June 30, 2024, and then turn the call back over to Dave for his closing remarks.
As a reminder, during today's call, we'll be making certain forward-looking statements. These forward-looking statements are based on current information, assumptions, estimates and projections about future events that are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements.
Investors should consider these risks and other information described in our filings made with the Securities and Exchange Commission, including our quarterly report on Form 10-Q, which we filed on Thursday, August 08, 2024. You are cautioned not to place any undue reliance on these forward-looking statements and Acurx disclaims any obligation to update such statements at any time
- Read more current ACXP analysis and news
- View all earnings call transcripts